- June 02-06, 2017
ASCO 2017, Chicago, Illinois
- September 08-12, 2017
ESMO, European Society for Medical Oncology Congress, Madrid, Spain
- September 26th, 2017
Ladenburg Thalmann 2017 Healthcare Conference, Sofitel, New York
- October 31th , 2017
World Immunotherapy Congress, Basel, Switzerland.
is speaking about TACTI-mel, two ACTive immunotherapies in melanoma: combination of an APC activator (IMP321 or LAG-3Ig) with Pembrolizumab at 5:50 PM.
- November 08-12, 2017
SITC, Society for Immunotherapy of Cancer, National Harbor, MD, USA
- November 2017
Annual General Meeting
in November 2017